- Home
- BBCP vs CLYM Comparison
BBCP vs CLYM Comparison
Compare BBCP & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBCP
- CLYM
- Stock Information
- Founded
- BBCP 1983
- CLYM 2018
- Country
- BBCP United States
- CLYM United States
- Employees
- BBCP N/A
- CLYM N/A
- Industry
- BBCP Engineering & Construction
- CLYM
- Sector
- BBCP Consumer Discretionary
- CLYM
- Exchange
- BBCP Nasdaq
- CLYM NYSE
- Market Cap
- BBCP 297.1M
- CLYM 242.8M
- IPO Year
- BBCP 2017
- CLYM 2021
- Fundamental
- Price
- BBCP $5.60
- CLYM $3.79
- Analyst Decision
- BBCP Buy
- CLYM
- Analyst Count
- BBCP 4
- CLYM 0
- Target Price
- BBCP $7.67
- CLYM N/A
- AVG Volume (30 Days)
- BBCP 66.9K
- CLYM 336.3K
- Earning Date
- BBCP 09-04-2024
- CLYM 11-15-2024
- Dividend Yield
- BBCP N/A
- CLYM N/A
- EPS Growth
- BBCP N/A
- CLYM N/A
- EPS
- BBCP 0.26
- CLYM N/A
- Revenue
- BBCP $434,594,000.00
- CLYM N/A
- Revenue This Year
- BBCP N/A
- CLYM N/A
- Revenue Next Year
- BBCP N/A
- CLYM N/A
- P/E Ratio
- BBCP $21.55
- CLYM N/A
- Revenue Growth
- BBCP N/A
- CLYM N/A
- 52 Week Low
- BBCP $5.05
- CLYM $2.35
- 52 Week High
- BBCP $8.48
- CLYM $11.55
- Technical
- Relative Strength Index (RSI)
- BBCP 50.61
- CLYM N/A
- Support Level
- BBCP $5.59
- CLYM N/A
- Resistance Level
- BBCP $6.14
- CLYM N/A
- Average True Range (ATR)
- BBCP 0.18
- CLYM 0.00
- MACD
- BBCP 0.02
- CLYM 0.00
- Stochastic Oscillator
- BBCP 34.75
- CLYM 0.00
About BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.